In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier

ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20410-20416. doi: 10.1021/acsami.7b03504. Epub 2017 Jun 12.

Abstract

A brain drug delivery system has been demonstrated by attaching lactoferrin (Lf) on the silica nanoparticles (Si NPs). The nanoparticle surface was modified with polyethylene glycol to reduce protein adsorption. The transport efficiency of Lf attached Si NPs was studied using an in vitro blood-brain barrier (BBB) model consisting of three distinct types of cells: endocytes, pericytes, and astrocytes. Transfer of NPs from the apical side to the basolateral side is observed. The results indicated that Lf attached Si NPs demonstrated enhanced transport efficiency across the BBB with size-dependence compared to bare Si NPs. The maximum transport efficiency of lactoferrin conjugated silica nanoparticle was observed for 25 nm diameter particles. This receptor-mediated transcytosis of Si NPs across the cerebral endothelial cells can be employed to deliver drugs and imaging probes to the brain.

Keywords: blood−brain barrier; lactoferrin; receptor; silica nanoparticles; transcytosis.

MeSH terms

  • Blood-Brain Barrier
  • Brain
  • Drug Delivery Systems
  • Nanoparticles*
  • Polyethylene Glycols
  • Silicon Dioxide

Substances

  • Polyethylene Glycols
  • Silicon Dioxide